世界の肝臓癌診断市場規模は2028年までに174億米ドルに達する見込みです。同市場は、2021年から2028年にかけて、7.5%のCAGRで拡大すると予測されています。肝臓癌の有病率の上昇と、革新的な診断製品の登場が市場の成長を後押ししています。
Globocan社が発表したデータによると、肝臓癌は癌の中で6番目に多いタイプであり、2020年には世界全体で約905,677件の新規症例が診断され、約830,180人が死亡するという生命を脅かす疾患であることがわかりました。肝臓癌の最も一般的な原因は、C型肝炎ウイルス（HCV）またはB型肝炎ウイルス（HBV）の慢性（長期）感染です。WHOの推計によると、世界では約7,100万人がHCVに慢性的に感染しているとされています。同じ資料によると、2016年には、HCV感染に関連する肝硬変や原発性肝臓癌で約39万9,000人が死亡しています。このような高い罹患率と死亡率により、タイムリーな診断のための革新的な診断ソリューションに対する需要が大幅に高まり、市場成長を支えています。
さらに、癌診断分野における継続的な技術進歩と、より効率的な診断ツールへのアクセスの増加が、予測期間中の市場成長を支えると考えられます。2020年9月、中国を拠点とする腫瘍診断会社であるGenetron Holdings Limited社は、血液ベースの次世代シーケンシング（NGS）テストであるHCCscreenのFDAの画期的なデバイス指定を受けました。この新たに開始されたテストは、肝硬変および/または慢性HBV感染のために肝細胞癌（HCC）のリスクが高いと疑われる患者の肝細胞癌（HCC）の早期発見のために設計されています。
さらに、肝臓癌を含むさまざまながんの早期診断のためのスクリーニングを強化するために、いくつかの国で官民一体となった継続的な取り組みが行われており、市場の成長を促す環境が整っていると考えられます。2019年、サウジアラビアの保健省は、スクリーニングプログラムの進歩、癌に対する意識の向上、地域全体での新しい腫瘍学センターの設立など、いくつかのイニシアチブに着手することを発表しました。 2019年、Cleveland Clinic Abu Dhabiは、増大する需要に対応するために、国内で強化された範囲の肝臓癌サービスを導入することを発表しました。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR's internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Liver Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing prevalence of liver cancer
3.3.1.2 Technological advancements
3.3.1.3 Rising initiatives undertaken by public and private organizations
3.3.1.4 Increasing prevalence of risk factors for liver cancer
3.3.2 Market Restraint Analysis
3.3.2.1 High cost of diagnostic imaging
3.3.2.2 Radiation exposure likely to limit usage of CT
3.3.3 Industry challenges
3.3.3.1 Lack of evidence for the efficacy of whole-body liver cancer diagnostics
3.3.4 Industry opportunities
3.3.4.1 Growing focus on expanding liver cancer diagnostics applications
3.4 Liver Cancer Diagnostics Market Analysis Tools
3.4.1 Industry analysis - Porter's
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
Chapter 4 Liver Cancer Diagnostics Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Liver Cancer Diagnostics Market: Test Type Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Test Type Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Liver Cancer Diagnostics Market, by Test Type, 2016 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.5.1 Laboratory Tests
5.5.1.1 Laboratory Tests Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.2 Biomarkers
5.5.1.2.1 Biomarkers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.2.2 Oncofetal and Glycoprotein Antigens
5.5.1.2.2.1 Oncofetal and Glycoprotein Antigens Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.2.3 Enzymes and Isoenzymes
5.5.1.2.3.1 Enzymes and Isoenzymes Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.2.4 Growth Factors and Receptors
5.5.1.2.4.1 Growth Factors and Receptors Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.2.5 Molecular Markers
5.5.1.2.5.1 Molecular Markers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.2.6 Pathological Biomarkers
5.5.1.2.6.1 Pathological Biomarkers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.3 Blood Tests
5.5.1.3.1 Blood Tests Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.2 Imaging Tests
5.5.2.1 Imaging Tests Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3 Endoscopy
5.5.3.1 Endoscopy Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.4 Biopsy
5.5.4.1 Biopsy Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.5 Others
5.5.5.1 Others Market Estimates and Forecasts, 2016 to 2028 (USD Million)
Chapter 6 Liver Cancer Diagnostics Market: End-use Estimates And Trend Analysis
6.1 Definition & Scope
6.2 End-use Market Share Analysis, 2020 & 2026
6.3 Segment Dashboard
6.4 Global Liver Cancer Diagnostics Market, by End Use, 2016 to 2026
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2026
6.5.1 Hospitals & Diagnostic Laboratories
6.5.1.1 Hospitals & Diagnostic Laboratories Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.2 Academic & Research Institutes
6.5.2.1 Academic & Research Institutes Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.3 Pharmaceutical & CRO Laboratories
6.5.3.1 Pharmaceutical & CRO Laboratories Market Estimates and Forecasts, 2016 to 2028 (USD Million)
Chapter 7 Liver Cancer Diagnostics Market: Regional Estimates & Trend Analysis
7.1 Regional Market Snapshot
7.2 Regional Market Share and Leading Players, 2020
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa
7.3 Market Share Analysis by Country, 2020
7.3.1 North America
7.3.1.1 U.S.
7.3.1.2 Canada
7.3.2 Europe
7.3.2.1 U.K.
7.3.2.2 Germany
7.3.2.3 Spain
7.3.2.4 France
7.3.2.5 Italy
7.3.2.6 Russia
7.3.3 Asia Pacific
7.3.3.1 Japan
7.3.3.2 China
7.3.3.3 India
7.3.3.4 South Korea
7.3.3.5 Singapore
7.3.3.6 Australia
7.3.4 Latin America
7.3.4.1 Brazil
7.3.4.2 Mexico
7.3.4.3 Argentina
7.3.5 Middle East & Africa
7.3.5.1 South Africa
7.3.5.2 Saudi Arabia
7.3.5.3 UAE
7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.4.1 North America
7.4.2 Europe
7.4.3 Asia Pacific
7.4.4 Latin America
7.4.5 Middle East & Africa
7.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2028
7.5.1 North America
7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.1.2 U.S.
7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.3 Canada
7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.2 Europe
7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.2.2 U.K.
7.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.2.3 Germany
7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.2.4 Spain
7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.2.5 France
7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.2.6 Italy
7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.2.7 Russia
7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.3 Asia Pacific
7.5.3.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.3.2 Japan
7.5.3.2.1 Japan Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.3.2.2 Japan Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.3.3 China
7.5.3.3.1 China Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.3.3.2 China Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.3.4 India
7.5.3.4.1 India Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.3.4.2 India Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.3.5 South Korea
7.5.3.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.3.5.2 South Korea Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.3.6 Singapore
7.5.3.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.3.6.2 Singapore Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.3.7 Australia
7.5.3.7.1 Australia Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.3.7.2 Australia Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.4 Latin America
7.5.4.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.4.2 Brazil
7.5.4.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.4.2.2 Brazil Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.4.3 Mexico
7.5.4.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.4.3.2 Mexico Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.4.4 Argentina
7.5.4.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.4.4.2 Argentina Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.5 Middle East & Africa
7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.5.2 South Africa
7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.5.3 Saudi Arabia
7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.5.4 UAE
7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2028 (USD Million)
7.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
Chapter 8 Company Profile
8.1 Company Profiles
8.1.1 Abbott Laboratories
8.1.1.1 Company overview
8.1.1.2 Financial Performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 F. Hoffmann-La Roche Ltd.
8.1.2.1 Company overview
8.1.2.2 Financial Performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Qiagen N.V.
8.1.3.1 Company overview
8.1.3.2 Financial Performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 Thermo Fisher Scientific, Inc.
8.1.4.1 Company overview
8.1.4.2 Financial Performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Siemens Healthineers
8.1.5.1 Company overview
8.1.5.2 Financial Performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Becton Dickinson & Company
8.1.6.1 Company overview
8.1.6.2 Financial Performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Illumina, Inc.
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Koninklijke Philips N.V.
8.1.8.1 Company overview
8.1.8.2 Financial Performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 Epigenomics AG
8.1.9.1 Company overview
8.1.9.2 Financial Performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Fujifilm Medical Systems U.S.A., Inc.
8.1.10.1 Company overview
8.1.10.2 Financial Performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
LIST OF TABLES
Table 1 List secondary sources
Table 2 North America liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 3 North America liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 4 U.S. liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 5 U.S. liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 6 Canada liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 7 Canada liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 8 Europe liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 9 Europe liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 10 Germany liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 11 Germany liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 12 U.K. liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 13 U.K. liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 14 France liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 15 France liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 16 Italy liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 17 Italy liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 18 Spain liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 19 Spain liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 20 Russia liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 21 Russia liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 22 Asia Pacific liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 23 Asia Pacific liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 24 China liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 25 China liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 26 India liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 27 India liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 28 Australia liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 29 Australia liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 30 Japan liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 31 Japan liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 32 South Korea liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 33 South Korea liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 34 Singapore liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 35 Singapore liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 36 Latin America liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 37 Latin America liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 38 Brazil liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 39 Brazil liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 40 Mexico liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 41 Mexico liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 42 Argentina liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 43 Argentina liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 44 MEA liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 45 MEA liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 46 South Africa liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 47 South Africa liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 48 Saudi Arabia liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 49 Saudi Arabia liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 50 UAE liver cancer diagnostics market estimates and forecasts, by test type, 2016 - 2028 (USD Million)
Table 51 UAE liver cancer diagnostics market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot, 2020 (USD Million)
Fig. 9 Liver cancer diagnostics market segmentation
Fig. 10 Penetration & growth prospect mapping for test type, 2020
Fig. 11 Penetration & growth prospect mapping for end use, 2020
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Industry challenges
Fig. 15 Company/competition categorization (key innovators, market leaders, emerging players)
Fig. 16 Strategy framework
Fig. 17 Market participation categorization
Fig. 18 Company position analysis
Fig. 19 Liver cancer diagnostics market: Test type outlook and key takeaways
Fig. 20 Liver cancer diagnostics market: Test type movement analysis
Fig. 21 Laboratory tests market, 2016 - 2028 (USD Million)
Fig. 22 Imaging tests market, 2016 - 2028 (USD Million)
Fig. 23 Endoscopy market, 2016 - 2028 (USD Million)
Fig. 24 Biopsy market, 2016 - 2028 (USD Million)
Fig. 25 Others market, 2016 - 2028 (USD Million)
Fig. 26 Liver cancer diagnostics market: End-use outlook and key takeaways
Fig. 27 Liver cancer diagnostics market: End-use movement analysis
Fig. 28 Hospitals & diagnostic laboratories market, 2016 - 2028 (USD Million)
Fig. 29 Academic & research institutes market, 2016 - 2028 (USD Million)
Fig. 30 Pharmaceutical & CRO laboratories market, 2016 - 2028 (USD Million)
Fig. 31 Liver cancer diagnostics market: Regional outlook and key takeaways
Fig. 32 Liver cancer diagnostics market: Regional movement analysis
Fig. 33 North America
Fig. 34 North America liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 35 U.S.
Fig. 36 U.S. liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 37 Canada
Fig. 38 Canada liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 Europe
Fig. 40 Europe liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 41 Germany
Fig. 42 Germany liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 43 U.K.
Fig. 44 U.K. liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 France
Fig. 46 France liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 Italy
Fig. 48 Italy liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 Spain
Fig. 50 Spain liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 51 Russia
Fig. 52 Russia liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 53 Asia Pacific
Fig. 54 Asia Pacific liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 55 Japan
Fig. 56 Japan liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 57 China
Fig. 58 China liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 59 India
Fig. 60 India liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 61 South Korea
Fig. 62 South Korea liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 63 Australia
Fig. 64 Australia liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 65 Singapore
Fig. 66 Singapore liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 67 Latin America
Fig. 68 Latin America liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 69 Brazil
Fig. 70 Brazil liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 71 Mexico
Fig. 72 Mexico liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 73 Argentina
Fig. 74 Argentina liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 75 MEA
Fig. 76 MEA liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 77 South Africa
Fig. 78 South Africa liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 79 Saudi Arabia
Fig. 80 Saudi Arabia liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 81 UAE
Fig. 82 UAE liver cancer diagnostics market estimates and forecast, 2016 - 2028 (USD Million)
